Showing results (121-130 of 293) with videos related to

Sort By:
Pageof 30
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 26, 2013
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementDon Husereau, Michael Drummond, Stavros Petrou, et al.
Blood Advances|January 4, 2018
Depression, quality of life, and medical resource utilization in sickle cell diseaseSoheir S Adam, Charlene M Flahiff, Shital Kamble, et al.
World Journal of Surgery|July 9, 2015
Minimally Invasive Distal Pancreatectomy for Cancer: Short-Term Oncologic Outcomes in 1,733 PatientsMohamed Abdelgadir Adam, Kingshuk Choudhury, Paolo Goffredo, et al.
Clinical Transplantation|January 22, 2005
Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantationJasmina I Radeva, Shelby D Reed, Zoltán Kaló, et al.
Neurosurgery|December 29, 2007
Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003Alisa M Shea, Shelby D Reed, Lesley H Curtis, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 29, 2022
Patient-Preference Diagnostics: Adapting Stated-Preference Methods to Inform Effective Shared Decision MakingJuan Marcos Gonzalez Sepulveda, F Reed Johnson, Shelby D Reed, et al.
Therapeutic Innovation & Regulatory Science|May 2, 2018
Effective Partnering in Conducting Benefit-Risk Patient Preference Studies: Perspectives From a Patient Advocacy Organization, a Pharmaceutical Company, and Academic Stated-Preference ResearchersAnne M Wolka, Angelyn O Fairchild, Shelby D Reed, et al.
BMC Pediatrics|October 20, 2004
Parents' reported preference scores for childhood atopic dermatitis disease statesJoëlle Y Friedman, Shelby D Reed, Kevin P Weinfurt, et al.
Neurosurgery|July 21, 2010
Costs of vasospasm in patients with aneurysmal subarachnoid hemorrhageChia-Hung Chou, Shelby D Reed, Jennifer S Allsbrook, et al.
Cancer Medicine|July 19, 2025
Quantifying Preferences for CAR-T Compared to Standard of Care as a First-Line Treatment Among Patients With Multiple MyelomaJessie Sutphin, Thomas W LeBlanc, Ellen Janssen, et al.
Pageof 30